Altered p53 and pRb expression is predictive of response to BCG treatment in T1G3 bladder cancer. [electronic resource]
- Anticancer research Oct 2009
- 4201-4 p. digital
Publication Type: Journal Article
1791-7530
Administration, Intravesical Aged Aged, 80 and over BCG Vaccine--administration & dosage Biomarkers, Tumor--biosynthesis Disease-Free Survival Female Humans Male Middle Aged Neoplasm Staging Retinoblastoma Protein--biosynthesis Tumor Suppressor Protein p53--biosynthesis Urinary Bladder Neoplasms--metabolism